GLP-1 is one of the main hormone pathways involved in appetite control
Many doctors now prescribe Mounjaro (or the obesity-labeled version Zepbound ) for patients who meet criteria (generally a BMI 30, or 27 with weight-related conditions)
For semaglutide, that could mean starting at 0 } Potential Benefits of Microdosing GLP-1 Clinical trials have not specifically evaluated GLP-1 microdosing at sub-standard doses, and off-label lower-dose approaches have not been validated in randomized controlled trials
This includes follow-up care, ongoing lifestyle coaching, and access to additional resources to ensure that patients have the tools they need to sustain their healthy habits and prevent weight regain
As GLP-1 receptor agonists have become one of the most widely prescribed drug classes in the United States for weight loss and type 2 diabetes, hair loss has emerged as a real, documented, and increasingly common concern among patients in Newport Beach, Orange County, Los Angeles, and across California
